Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant

NCT06129734 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Myeloid Malignancy
Acute Myeloid Leukemia

Interventions

DRUG: Venetoclax
DRUG: Decitabine

Sponsor

Benjamin Tomlinson